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Personalized medicine is becoming an important part of medicine, for
instance predicting individual drug responses or risk of complications based
on genomic information. However, many current statistical methods are not
tailored to this task, because they overlook the individual heterogeneity
of patients. In this paper, we look at personalized medicine from a lin-
ear regression standpoint. We introduce an alternative version of the ridge
estimator and target individuals by establishing a tuning parameter cali-
bration scheme that minimizes prediction errors of individual patients. In
stark contrast, classical schemes such as cross-validation minimize predic-
tion errors only on average. We show that our pipeline is optimal in terms
of oracle inequalities, fast, and highly effective both in simulations and on
real data.
1. Introduction. In the last decade, improvements in genomic, transcrip-
tomic, and proteomic technologies have enabled personalized medicine (also called
precision medicine) to become an essential part of contemporary medicine. Person-
alized medicine takes into account individual variability in genes, proteins, environ-
ment, and lifestyle to decide on optimal disease treatment and prevention (Hamburg
and Collins, 2010). The use of a patient’s genetic and epigenetic information has
already proven to be highly effective to tailor drug therapies or preventive care in a
number of applications, such as breast cancer (Cho, Jeon and Kim, 2012), prostate
cancer (Nam et al., 2007), ovarian cancer (Hippisley-Cox and Coupland, 2015), and
pancreatic cancer (Ogino et al., 2011), cardiovascular disease (Ehret et al., 2011),
cystic fibrosis (Waters et al., 2018), and psychiatry (Demkow and Wolan´czyk, 2017).
The subfield of pharmacogenomics studies specifically how genes affect a person’s
response to particular drugs to develop more efficient and safer medications (Ziegler
et al., 2012).
Genomic, epigenomic, and transcriptomic data used in precision medicine, such
as gene expression, copy number variants, or methylation levels are typically high-
dimensional with a number of variables that rivals or exceeds the number of ob-
servations. Using such data to estimate and predict treatment response or risk of
complications, therefore, requires regularization typically by the `1 norm (lasso), the
`2 norm (ridge), or other terms. Ridge regression (Hoerl and Kennard, 1970) yields
good predictive performance for dense or non-sparse effects, that is, for outcomes
related to systemic conditions, as the method does not perform variable selection.
Ridge regression has become a standard tool for prediction based on genomic data,
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and it has been shown that ridge regression can outmatch competing prediction
methods for survival based on gene expression (Bøvelstad et al., 2007,Cule and De
Iorio, 2013).
However, regularization always introduces one or more tuning parameters. These
tuning parameters are usually calibrated based on the averaged prediction risks.
Most commonly used, K-fold cross-validation (CV) divides the data into K folds
(typically K ∈ {5, 10}), predicts each fold out-of-sample, averages over all folds
for a range of tuning parameters, and selects the value with the lowest averaged
error (Stone, 1974, Golub, Heath and Wahba, 1979). But the averaging removes
the inherent individual heterogeneity of the patients and can, therefore, result in
sub-optimal prediction performance. This may ultimately lead to unsuitable treat-
ment, administration of improper medication with adverse side effects, or lack of
preventive care (Hamburg and Collins, 2010).
Hence, rather than minimizing an averaged prediction error, our goal is to mini-
mize each patient’s individual (“personalized”) prediction error. A na¨ıve two-stage
personalized procedure for ridge regression was recently proposed by (Hellton and
Hjort (2018)). In this paper, we introduce an alternative ridge estimator, referred
to as euclidean distance ridge (edr), and calibrate the tuning parameter using adap-
tive validation (Lepskii, 1992, Spokoiny, Mammen and Lepsiki, 1997) individually
for each patient. We show that this approach offers compelling theory, fast compu-
tations, and accurate prediction on data.
The specific motivation for our method is to unravel the relationship between
gene expression and weight gain in kidney transplant recipients (Cashion et al.,
2013). Kidney transplant recipients are known to often gain substantial weight
during the first year after transplantation, which can result in adverse health ef-
fects (Patel, 1998). Individual predictions of this weight gain based on the genetic
data could help in providing each patient with the best possible care.
The remainder of this paper is organized as follows: We introduce the linear re-
gression framework and the problem statement in Section 2. We then introduce the
main methodology of our approach, and present theoretical guarantees in Section 3.
In addition, we discuss the algorithm and analyze its performance through simula-
tion studies using synthetic and real data in Section 4. We further apply our pipeline
to kidney transplant data in Section 5. Finally, we discuss the results in Section 6
and we defer all proofs to the Appendix. All data are publicly available and our
code is available at https://github.com/LedererLab/personalized_medicine.
2. Problem Setup. We consider data (y,X) that follows a linear regression
model
y = Xβ∗ + u. (2.1)
Let p denote the number of parameters, e.g. genes or genetic probes, and n the
number of samples or patients, then y ∈ Rn is the vector of outcomes, yi, for
example, a persons response to treatment. We let X denote the design matrix,
where each row xi ∈ Rp, i ∈ {1, . . . n}, contains the genome information of the
corresponding person. Each element β∗j , j ∈ {1, . . . p}, of the regression vector β∗ ∈
Rp models the gene’s influence on the person’s response. We ensure the uniqueness
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of β∗ by assuming that it is a projection onto the linear space generated by the n
rows of X (Shao and Deng, 2012, Bu¨hlmann, 2013). For the random error vector
u ∈ Rn, we make no assumptions on the probability distribution.
Our goal is to estimate the regression vector β∗ from data (y,X), or in terms
of our application, predicting a person’s treatment response based on that person’s
genome information. Mathematically, this amounts to estimating z>β∗ in terms of
the personalized prediction error ∣∣z>(β∗ − βˆ)∣∣, (2.2)
where z ∈ Rp is the person’s genome information.
Since the data in precision medicine is typically high-dimensional, that is, the
number of parameters (genes) p exceeds the number of samples (patients) n, we
consider regularized least-squares estimators of the form
βˆ
[
r
] ∈ arg min
β∈Rp
{
||y −Xβ||22 + r · f [β]
}
. (2.3)
Here, f denotes a function that takes into account prior information, such as sparsity
or smaller regression coefficients, and the tuning parameter r ≥ 0 balances the least-
squares term and the prior term.
Given an estimator (2.3), the main challenge is to find a good tuning parameter
in line with our statistical goal. This means that we want to mimic the tuning
parameter
r∗ := arg min
r∈R
∣∣∣z>(β∗ − βˆ[r])∣∣∣,
which is the optimal tuning parameter in a given set of candidate parameters R :=
{r1, r2, . . . , rm}.
The optimal tuning parameter r∗ depends on the family of estimators (2.3), the
unknown noise u, and the patient’s genome information z. The dependence on z is
integral to personalized medicine: different patients can respond very differently to
the same treatment. But standard tuning parameter calibration such as CV schemes
do not take this personalization into account but instead attempt to minimize
the averaged prediction error ||Xβ∗ − Xβˆ[r]||22/n rather than the personalized
prediction error
∣∣z>(β∗− βˆ[r])∣∣. We, therefore, develop a new prediction pipeline,
that is tailored to the personalized prediction error and equip our methods with
fast algorithms and sharp guarantees.
3. Methodology. In this section, we introduce an alternative version of the
ridge estimator (Hoerl and Kennard, 1970) along with a calibration scheme tailored
to personalized medicine. Two distinct features of the pipeline are its finite-sample
bounds and its computational efficiency. Our estimator is called euclidean distance
ridge (edr) and is defined as
βˆedr
[
r
] ∈ arg min
β∈Rp
{
||y −Xβ||22 + r||β||2
}
. (3.1)
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The edr replaces the ridge estimator’s squared `2 prior term fridge[β] ≡ ||β||22
by its square-root fedr[β] ≡
√
fridge[β] ≡ ||β||2. This modification allows us to
derive finite-sample oracle inequalities that can be leveraged for tuning parameter
calibration. At the same time, the edr preserves two of the ridge estimator’s most
attractive features: it can model the influences of many parameters, and it can be
computed without the need for elaborate descent algorithms (see Section 4).
Our first step is to establish finite-sample guarantees for the edr. The key idea is
that if the tuning parameter is large enough, the personalized prediction error (2.2)
is bounded by a multiple of the tuning parameter. For ease of presentation, we
assume an orthonormal design, that is, X>X = Ip×p and defer the discussion of
correlated covariates to the Appendix C. However, simulations with more general
designs are carried out in Section 4. We establish the following guarantee for edr:
Lemma 3.1 (Oracle inequality for edr). If r ≥ 2∣∣(Xz)>u∣∣/(c[z, r]||z||2), where
c
[
z, r
]
:=
∣∣z>βˆedr[r]∣∣
||z||2||βˆedr
[
r
]||2 ∈ [0, 1],
then it holds for orthonormal design that∣∣z>(β∗ − βˆedr[r])∣∣ ≤ c[z, r] · ||z||2 · r.
Such guarantees are usually called oracle inequalities (Lederer et al., 2019). The
given oracle inequality is an ideal starting point for our pipeline, because it gives us a
mathematical handle on the quality of tuning parameters: a good tuning parameter
should be large enough to meet the stated condition and yet small enough to give
a sharp bound. The original ridge estimator, however, lacks such inequalities for
personalized prediction.
Our proof techniques, which are based on the optimality conditions of the estima-
tor, also yield a similar bound for the original ridge estimator: if t ≥ ∣∣(Xz)>u∣∣/||z||2,
then
∣∣z>(β∗ − βˆridge[t])∣∣ ≤ ∣∣1 + z>βˆridge[t]/||z||2∣∣ · ||z||2 · t. The following pipeline
can then be applied the same way as for the edr. But the crucial advantage of the
edr’s bound is that its right-hand side is bounded by ||z||2 · r, which ensures that
the results do not scale with β∗.
The factor c
[
z, r
]
can be interpreted as the absolute value of the correlation
between the person’s genome information z and the estimator βˆedr
[
r
]
. This factor,
and therefore z, are included in our calibration scheme below, and our pipeline,
hence, optimizes the prediction for particular study subjects.
Lemma 3.1 bounds the personalized prediction error of edr as a function of the
tuning parameter r. Given z, the best tuning parameter in terms of the bound
minimizes c
[
z, r
] · r over all tuning parameters, that satisfy the lower bound
r ≥ 2
∣∣(Xz)>u∣∣
c
[
z, r
]||z||2 .
This tuning parameter value, which we call the oracle tuning parameter, can be
interpreted as the closest theoretical mimic of the optimal tuning parameter r∗.
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Definition 3.1 (Oracle tuning parameter for personalized prediction). Given
a new person’s genome information z, the oracle tuning parameter for personalized
prediction in a candidate set R is given by
ro ∈ arg min
r∈R¯
{
c
[
z, r
] · r}, where R := {r ∈ R : r ≥ 2∣∣(Xz)>u∣∣
c
[
z, r
]||z||2
}
.
The oracle tuning parameter ro is the best approximation of the optimal tuning
parameter r∗ in view of the mathematical theory expressed by Lemma 3.1. In
practice, however, one does not know the target β∗ nor the noise u (typically not
even its distribution), such that neither r∗ nor ro are accessible.
In the following our goal is, consequently, to match the prediction accuracy
of ro (and, therefore, of r
∗ essentially) with a completely data-driven scheme. Our
proposal is based on pairwise tests along the tuning parameter path:
Definition 3.2 (PAVedr : Personalized adaptive validation for edr). We select
a tuning parameter rˆ by
rˆ ∈ arg min
r∈RA
{
c
[
z, r
] · r · ||z||2}, (3.2)
where the set of admissible tuning parameters is
RA :=
{
r ∈ R
∣∣∣∣ max
r′,r′′∈R
r′,r′′≥r
[∣∣z>(βˆedr[r′]− βˆedr[r′′])∣∣
− (c[z, r′] · r′ + c[z, r′′] · r′′)||z||2 ≤ 0]}.
The idea of using pairwise tests for tuning parameter calibration in high-dimensional
statistics has been introduced by (Chichignound, Lederer and Wainwright (2016))
under the name adaptive validation. A difference here is that the factors c
[
z, r
] · r
are not constant but depend both on r and z. The dependence on z in particular
reflects our focus on personalized prediction.
The following result guarantees that the data-driven choice rˆ indeed provides—
up to a constant factor 3—the same performance as the oracle tuning parameter ro.
Theorem 3.1 (Optimality for personalized adaptive validation for edr). Under
the conditions of Lemma 3.1, it holds that∣∣z>(β∗ − βˆedr[rˆ])∣∣ ≤ 3 c[z, ro] · ||z||2 · ro.
This result guarantees that our calibration pipeline selects an essentially optimal
tuning parameter from any grid R. Our pipeline is the only method for tuning pa-
rameter selection in personalized medicine that is equipped with such finite-sample
guarantees. It does, moreover, not require any knowledge about the regression vec-
tor β∗ nor the noise u.
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Our calibration method is fully adaptive to the noise distribution; however, it
is instructive to exemplify our main result by considering Gaussian noise (see Ap-
pendix A.3 for the detailed derivations):
Example 3.1 (Gaussian noise). Suppose orthonormal design and Gaussian
random noise u ∼ Nn[0n, σ2In×n/n]. For any δ ∈ (0, 1), it holds with probabil-
ity at least 1− δ that
∣∣z>(β∗ − βˆedr[rˆ])∣∣ ≤ 3σ
√
8 log(2/δ)
n
||z||2.
The bound provides the usual parametric rate σ/
√
n in the number of samples n;
the factor ||z||2 entails the dependence on the number of parameters p.
4. Algorithm and Numerical Analysis. One of the main features of our
pipeline is its efficient implementation. This implementation exploits a fundamental
property of our estimator: there is a one-to-one correspondence between the edr and
the ridge estimator via the tuning parameters.
4.1. Connections to the ridge estimator. The ridge estimator is the `22-regularized
least-squares estimator (Hoerl and Kennard, 1970)
βˆridge
[
t
] ∈ arg min
β∈Rp
{
||y −Xβ||22 + t||β||22
}
, (4.1)
where t > 0 is a tuning parameter. Its computational efficiency, which is due to its
closed-form expression, provides a basis for the computation of our edr estimator.
The closed-form of the ridge estimator can be derived from the Karush-Kuhn-Tucker
(KKT) conditions as
βˆridge
[
t
]
= (X>X + tIp×p)−1X>y, (4.2)
noting that the matrix (X>X + tIp×p) is always invertible if t > 0.
However, the inversion of the matrix X>X + tIp×p still deserves some thought:
first, the matrix might be ill-conditioned, and second, the matrix needs to be com-
puted for a range of tuning parameters rather than only for a single one. A standard
approach to these two challenges is a singular value decomposition (svd) of the de-
sign matrix X.
Lemma 4.1 (Computation of the ridge estimator through singular value de-
composition). Let a singular value decomposition of X be given by X = UDV >,
where U ∈ Rn×n and V ∈ Rp×p are orthonormal matrices, and D = diag(d1, d2, ..., dp)
is an n×p diagonal matrix of the corresponding singular values d1, d2, ..., dp. Then,
the ridge estimator can be computed as
βˆridge
[
t
]
= V D†U>y, (4.3)
where D† ∈ Rp×n is diagonal with D† = diag(d1/(d21 + t), ..., dp/(d2p + t)).
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The singular value decomposition of the design matrix does not depend on the tun-
ing parameter; therefore, the ridge estimators βˆridge
[
t
]
can be readily computed for
multiple tuning parameters just by substituting the value of t in D†. The resulting
set of ridge (edr) estimators for a set of tuning parameters T is called the ridge
(edr) path for T .
Now, the crucial result is that the ridge estimator and the edr are computational
siblings.
Theorem 4.1 (One-to-one mapping between tuning parameters). The one-to-
one mapping φ[t] : t 7→ r defined by
r = φ[t] := ||2X>(y −Xβˆridge
[
t
]
)||2 (4.4)
transforms tuning parameters t of the ridge estimator to tuning parameters r of the
edr estimator such that βˆridge
[
t
]
= βˆedr
[
r
]
.
This mapping transforms, in particular, the optimal tuning parameter of the ridge
estimator to a corresponding optimal tuning parameter of the edr estimator. More
generally, it allows us to compute the edr estimator via the ridge estimator—see
below.
4.2. Algorithm. The core idea of our proposed algorithm is to exploit the above
one-to-one mapping between edr estimator and ridge estimator. This correspon-
dence allows us to compute edr solution paths efficiently via the ridge’s explicit
formulation and svd.
First, consider a set of ridge tuning parameters T and its corresponding set of
edr tuning parameters given by
Rφ :=
{
r ∈ R : r = φ[t], t ∈ T
}
with cardinality m := |Rφ|. This set contains, in particular, the tuning parame-
ter rˆ, whose optimality is guaranteed under Theorem 3.1. To compute the tuning
parameter rˆ, given data z, we first order the elements r1, r2, . . . , rm of Rφ such that
c
[
z, r1
] · r1 ≤ c[z, r2] · r2 ≤ · · · ≤ c[z, rm] · rm. (4.5)
The PAVedr method can then be formulated in terms of the binary random variables
sˆri :=
m∏
j=i
1
{∣∣z>(βˆedr[ri]− βˆedr[rj])∣∣− (c[z, ri] · ri + c[z, rj] · rj)||z||2 ≤ 0
}
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for i ∈ {1, . . . ,m}, and an algorithm is as follows:
Input:
(
ri
)
i=1,...,m
,
(
βˆedr
[
ri
])
i=1,...,m
, z
Result: rˆ
Set initial index: i← m
while sˆri 6= 0 and i > 1 do
Update index: i← i− 1
end
Set output: rˆ ← ri
Algorithm 1: Algorithm for PAVedr of Definition 3.2.
The full pipeline can be summarized by the following four steps:
Step 1: Generate a set T of tuning parameters for ridge regression.
Step 2: Compute the ridge solution path with respect to T by using (4.3).
Step 3: Transform the ridge tuning parameters to their edr counterparts Rφ
using (4.4) and sort the tuning parameters according to (4.5).
Step 4: Use the PAVedr method (Algorithm 1) to compute the tuning parame-
ter rˆ and map it back to its ridge counterpart tˆ.
The algorithm can be readily implemented and is fast: it essentially only requires
the computation of one ridge solution path (a single svd). In strong contrast, K-fold
CV requires the computation of K ridge solution paths. Consequently, the ridge
estimator with PAVedr can be computed approximately K times faster than with
K-fold CV, which we will confirm in the simulations. Moreover, CV still requires
a tuning parameter, namely, the number of folds K, while PAVedr is completely
parameter-free.
4.3. Simulation Study. We evaluate the prediction performance of the PAVedr
method using (1) fully simulated data with random design and (2) a real data set
with a simulated outcome. The results are compared to K-fold CV, which is a
standard reference method.
The first setting is solely based on simulated data. The dimensions of the design
matrix are (n, p) ∈ {(50, 100), (150, 250), (200, 500)}. First, the entries of the design
matrixX are sampled i.i.d. fromN [µ, 1], where the mean itself is sampled according
to µ ∼ N [0, 10], and the columns of the design matrix are then normalized to
have Euclidean norm equal to one. The entries of the regression vector β∗ are
sample i.i.d. from N [0, 1] and then projected onto the row space of X to ensure
identifiability (Shao and Deng, 2012, Bu¨hlmann, 2013). The entries of the noise
vector u are sampled i.i.d. from N [0, σ2], where σ2 = 2 Var[Xβ∗] to ensure a
signal-to-noise ratio of 0.5. Then, 100 data testing vectors z are sampled i.i.d.
from Up[−1, 1]. We generate a set of 300 tuning parameters T = {10q | q = −5 +
10i/299, i = 0, . . . , 299}.
The results are summarized in Table 1. The mean personalized prediction errors
for the testing vectors are averaged over 100 simulations as described above. The run
time is shown relative to PAVedr. We observe that in all considered cases, PAVedr
improves on CV both in terms of accuracy as well as in speed. A more detailed
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Table 1
For the first simulation setting, which entirely consists of artificial data, PAVedr outperforms
5-fold and 10-fold CV in accuracy and speed.
(n,p) Method Mean error (sd) Scaled run time
(50,100)
PAVedr 166.78 (242.46) 1.00
5-fold CV 340.18 (888.28) 1.57
10-fold CV 474.58 (1220.44) 3.64
(150,250)
PAVedr 433.50 (669.50) 1.00
5-fold CV 724.90 (1712.65) 3.43
10-fold CV 872.50 (2560.01) 8.04
(200,500)
PAVedr 805.94 (1316.43) 1.00
5-fold CV 1098.68 (2821.35) 3.65
10-fold CV 1144.12 (2733.78) 8.44
Fig 1: Run time of 10-fold CV scaled by the run time of PAVedr for a fixed num-
ber of observations n and fixed number of parameters p with p and n increasing,
respectively. We observe that PAVedr is faster than 10-fold CV.
analysis of the scaled run time for CV relative to PAVedr is shown in Figure 1. We
fix n with increasing p and vice versa. Observing that the gain in speed is less than
the factor K, because the computations of the ridge estimator are then fast enough
to compete with the sorting of the bounds in PAVedr.
In the second setting, we simulate the outcome but based on real data as co-
variates. The basis is the genomic data from the application in Section 5 where the
sample size or number of patient is n = 26. The number of covariates in the design
matrix is restricted to the p = 1936 gene probe targets identified as potentially
influential by (Cashion et al., 2013). The regression vector and the noise are then
generated as in the first simulation setting above. The results are summarized in
Table 2. We observe again that PAVedr improves on CV both in terms of accu-
racy as well as in speed. The results of this section demonstrate that PAVedr is a
contender on data, which confirms and complements our theoretical findings from
before.
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Table 2
In the second simulation setting, which consists of real covariate data and simulated outcomes,
PAVedr outperforms 5-fold and 10-fold CV again both in accuracy and speed.
Method Mean error (sd) Scaled run time
PAVedr 33.71 (34.73) 1.00
5-fold CV 164.06 (120.06) 4.02
10-fold CV 132.90 (97.31) 9.58
5. Application to kidney transplant patient data. Kidney transplant
recipients are known to gain significant weight during the first year after transplan-
tation, with a reported average increase of 12 kg (Patel, 1998). Such substantial
weight gain over a relatively short time period gives an increased risk for several
adverse health effects, such as cardiovascular disease, and may be detrimental for
the overall outcome of the patient. The weight gain has been explained by the use
of prescribed steroids which increase the appetite, but steroid-free protocols alone
have not reduced the risk of obesity, suggesting alternative causes. Even though
weight gain is fundamentally caused by a too high calorie intake relative to the
energy expenditure, the heterogeneity in the individual response is substantial. Ge-
netic variation has, therefore, been considered as a contributing factor, and several
genes have been linked to obesity and weight gain (Bauer et al., 2009, Cheung et
al., 2010).
(Cashion et al., 2013) investigated whether genomic data can be used to predict
weight gain in kidney transplant recipients. This was done by measuring gene ex-
pression in subcutaneous adipose tissue which has an important role in appetite reg-
ulation and can easily be obtained from the patients during surgery. The patients’
weight was recorded at the time of transplantation and at a 6-months follow-up
visit, resulting in a relative weight difference. The adipose tissue samples were col-
lected from 26 transplant patients at the time of surgery, and mRNA levels were
measured to obtain the gene expression profiles for 28 869 gene probe targets using
Affymetrix Human Gene 1.0 ST arrays1. The expression variability was further not
associated with gender or race (Cashion et al., 2013). As excessive weight gain may
have severe consequences for the patients, the goal is to predict the future weight
increase based on the available gene expression profiles. If a large weight increase is
predicted, additional measures such as diet restrictions or physiotherapy could be
set into effect.
We compare the performance of our method in predicting weight gain for the
kidney transplant patients to the prediction of standard ridge regression calibrated
by CV. In detail, we make predictions for each patient both in-sample and out-of-
sample, leaving out the observation and using the remaining data to fit the penalized
regression model and select the optimal tuning parameter. Since we do not know
the true parameter β∗, we can only examine the performance of our method and
CV by comparing their estimation errors, which is defined by
|yi − x>i βˆedr
[
r
]|. (5.1)
1All data are publicly available in the EMBL-EBI ArrayExpress database (www.ebi.ac.uk/
arrayexpress) under accession number E-GEOD-33070.
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Table 3
In the kidney transplant data, regardless of in-sample or leave-one-out prediction, PAVedr
outperforms 5-fold and 10-fold CV again both in accuracy and speed.
(a) In-sample prediction
Method Mean error (sd) Scaled run time
PAVedr 0.0049 (0.0121) 1.00
5-fold CV 0.0646 (0.0540) 1.19
10-fold CV 0.0666 (0.0584) 3.04
(b) Leave-one-out prediction
Method Mean error (sd) Scaled run time
PAVedr 0.0622 (0.0309) 1.00
5-fold CV 0.0672 (0.0415) 1.10
10-fold CV 0.0678 (0.0475) 2.82
As described in the previous section, the columns of the design matrix are normal-
ized to have Euclidean norm one. Unlike in the Section 4.3, we here take all the
28 869 gene probes into consideration.
The averaged results are summarized in Table 3a and Table 3b. We observe that
PAVedr clearly outperforms 5-fold and 10-fold CV for both in-sample and out-of-
sample prediction of the kidney transplant data. For out-of-sample prediction, we
observe an improvement of about 7.5% in the estimation error and an improvement
of 25.5% in the standard deviation compared to 5-fold CV. These improvements,
especially in standard deviation, reinforce the advantages of a personalized approach
to tuning parameter calibration.
6. Conclusion. We have introduced a pipeline that calibrates ridge regression
for personalized prediction. Its distinctive features are the finite sample guarantees
(see Theorem 3.1) and the statistical and computational efficiency (see Tables 1
and 2). These features are echoed when predicting the weight gain of kidney trans-
plant patients (see Table 3). Hence, our pipeline can improve personalized prediction
and, thereby, further the cause of personalized medicine.
Despite our focus on personalized medicine, we also envision applications in other
areas where individual heterogeneity is crucial for predictions. Two examples are
item recommendation, predicting the rating of an item or product assigned by a
specific user (Guy et al., 2010,Rafailidis et al., 2014), and personalized marketing,
delivering individualized product prices or messages to specific costumers (Tang,
Liao and Sun, 2013).
APPENDIX A: PROOFS
A.1. Proof of Lemma 3.1.
Proof. Assume r ≥ 2∣∣(Xz)>u∣∣/(c[z, r]||z||2) and orthonormal design X>X =
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Ip×p. According to the KKT conditions of the edr estimator, we have
r
βˆedr
[
r
]
||βˆedr
[
r
]||2 = 2X>(y −Xβˆedr[r])
= 2X>(Xβ∗ + u−Xβˆedr
[
r
]
)
= 2X>X(β∗ − βˆedr
[
r
]
) + 2X>u.
Hence,
X>X(β∗ − βˆedr
[
r
]
) = −X>u+ r
2
βˆedr
[
r
]
||βˆedr
[
r
]||2 . (A.1)
Let z ∈ Rp and multiply z> from the left to obtain
z>(β∗ − βˆedr
[
r
]
) = −z>X>u+ r
2
z>βˆedr
[
r
]
||βˆedr
[
r
]||2
where we use the assumption of orthonormal design. By taking absolute value on
both sides and applying the triangle inequality, we derive the following bound for
the personalized prediction error (2.2):
∣∣z>(β∗ − βˆedr[r])∣∣ ≤ ∣∣z>X>u∣∣+ r2 ∣∣z>βˆedr
[
r
]
||βˆedr
[
r
]||2 ∣∣
≤ r
2
c
[
z, r
]||z||2 + r
2
∣∣ z>βˆedr[r]
||z||2||βˆedr
[
r
]||2 ∣∣||z||2
= c
[
z, r
] · r · ||z||2,
since r ≥ 2∣∣(Xz)>u∣∣/(c[z, r]||z||2) by assumption. Finally, we obtain the bound∣∣z>(β∗ − βˆedr[r])∣∣ ≤ c[z, r] · ||z||2 · r, (A.2)
with
c
[
z, r
]
:=
∣∣z>βˆedr[r]∣∣
||z||2||βˆedr
[
r
]||2 .
A.2. Proof of Theorem 3.1.
Proof. Let z ∈ Rp and suppose that the linear regression model (2.1) is under
orthonormal design.
Bound on c
[
z, rˆ
] · rˆ: First, we show that c[z, rˆ] · rˆ ≤ c[z, ro] · ro. Let
c
[
z, rˆ
] · rˆ ≥ c[z, ro] · ro,
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then by definition of rˆ, there must exist two tuning parameters r′, r′′ with
r′ ≥ 2∣∣(Xz)>u∣∣/(c[z, r′]||z||2),
r′′ ≥ 2∣∣(Xz)>u∣∣/(c[z, r′′]||z||2),
such that ∣∣z>(βˆedr[r′]− βˆedr[r′′])∣∣ ≥ (c[z, r′] · r′ + c[z, r′′] · r′′) · ||z||2.
However, by Lemma (3.1), we have∣∣z>(β∗ − βˆedr[r′])∣∣ ≤ c[z, r′] · r′ · ||z||2
and ∣∣z>(β∗ − βˆedr[r′′])∣∣ ≤ c[z, r′′] · r′′ · ||z||2.
Applying the triangle inequality to the above displays and combining the results
yields ∣∣z>(βˆedr[r′]− βˆedr[r′′])∣∣ ≤ (c[z, r′] · r′ + c[z, r′′] · r′′) · ||z||2,
which leads to a contradiction to our assumption. Therefore, we obtain the following
bound with respect to ro:
c
[
z, rˆ
] · rˆ ≤ c[z, ro] · ro.
Bound on the personalized prediction error: Since c
[
z, rˆ
] · rˆ ≤ c[z, ro] ·ro,
we have ∣∣z>(βˆedr[rˆ]− βˆedr[ro])∣∣ ≤ (c[z, rˆ] · rˆ + c[z, ro] · ro) · ||z||2
≤ 2 · c[z, ro] · ro · ||z||2
Applying the triangle inequality, we ultimately find the bound∣∣z>(β∗ − βˆedr[rˆ])∣∣ = ∣∣z>(β∗ − βˆedr[ro]+ βˆedr[ro]− βˆedr[rˆ])∣∣
≤ ∣∣z>(β∗ − βˆedr[ro])∣∣+ ∣∣z>(βˆedr[ro]− βˆedr[rˆ])∣∣
≤ 3 · c[z, ro] · ro · ||z||2.
A.3. Proof of Example 3.1.
Lemma A.1 (Deviation inequality). For any standard normal variable V ∼
N1[0, 1], we have the following concentration bound
P
{∣∣V ∣∣ ≥ x} ≤ 2 exp{−x2
2
}
(x > 0).
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Proof. P
{
V > x
}
= P
{
eλV > eλx
}
for all λ. Now by Markov’s inequality,
P
{
eλV > eλx
} ≤ E[eλV ]
eλx
= e
λ2
2 −λx
For λ = x, we have P
{
V > x
} ≤ e−x22 . Since the standard normal distribution is
symmetric about 0, we obtain the desired result.
Using this concentration bound, we derive the results of Example 3.1.
Proof. Given a z ∈ Rp, Gaussian noise u ∼ Nn[0n, σ2In×n/n] with variance
σ2, and suppose that the linear regression model (2.1) is under orthonormal design.
We first show that P
{
2
∣∣(Xz)>u∣∣/(c[z, r]||z||2) ≥ rδ} ≤ δ for
rδ :=
σ||Xz||2
(c
[
z, r
]||z||2)
√
8 log(2/δ)
n
using the concentration bound, Lemma A.1:
P
{
2
∣∣(Xz)>u∣∣/(c[z, r]||z||2) ≥ rδ} = P{ ∣∣(Xz)>u∣∣σ||Xz||2
(c
[
z,r
]
||z||2)
√
1/n
≥ (c
[
z, r
]||z||2)rδ
2σ||Xz||2
√
1/n
}
≤ 2 exp{−(
σ||Xz||2
√
8 log(2/δ)
n
2σ||Xz||2
√
1/n
)2
2
}
= 2 exp
{
log(δ/2)
}
= δ.
Hence, rδ ≥ 2
∣∣(Xz)>u∣∣/c[z, ro]||z||2 holds with at least probability 1− δ. By The-
orem 3.1, we have with at least probability 1− δ:∣∣z>(β∗ − βˆedr[rˆ])∣∣ ≤ 3 c[z, ro] ro||z||2 (∣∣c[z, ro]∣∣ ≤ 1)
= 3 c
[
z, ro
] σ||Xz||2
c
[
z, ro
]||z||2
√
8 log(2/δ)
n
||z||2
= 3σ
√
8 log(2/δ)
n
||z||2. (orthonormal design)
A.4. Proof of Lemma 4.1.
Proof. Let X = UDV > be a singular value decomposition of X as given in
Lemma 4.1. Then by algebraic manipulation of Equation (4.2) the ridge estimator
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can be written as
βˆridge
[
t
]
= (X>X + tIp×p)−1X>y
= (V DTUTUDV > + tIp×p)−1V DU>y
= (V D2V > + tIp×p)−1V DU>y
= V (D2 + tIp×p)−1V >V DU>y
= V D†U>y,
where the matrix D† is defined as
D† = diag(
d1
d21 + t
, ...,
dp
d2p + t
).
A.5. Proof of Theorem 4.1.
Proof. We consider the KKT-conditions of (3.1) and replace the edr estimator
with the ridge estimator to obtain
r
βˆridge
[
t
]
||βˆridge
[
t
]||2 = 2X>(y −Xβˆridge[t]).
By taking the `2-norm of both sides and with r > 0, we obtain
r = ||2X>(y −Xβˆridge
[
t
]
)||2.
Thus, we can transform the ridge tuning parameter t to the edr tuning parameter r
with respect to the same estimator.
Moreover, there is a one-to-one relationship between edr and ridge. The ridge
estimator in (4.2) implies that
(X>X + tIp×p)βˆridge
[
t
]
= X>y,
and hence
tβˆridge
[
t
]
= X>(y −Xβˆridge
[
t
]
).
Since
r = ||2X>(y −Xβˆridge
[
t
]
)||2 = 2t||βˆridge
[
t
]||2,
we have
r
2||βˆridge
[
t
]||2 = t
and we finally conclude that βˆridge
[
t
]
= βˆedr
[
r
]
when r
2||βˆridge
[
t
]
||2
= t.
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APPENDIX B: BEYOND ORTHOGONALITY
To avoid digression, we have restricted the theories in the main body of the
paper to orthonormal design matrices. However, there are straightforward exten-
sions along established lines in high-dimensional theory. In general, the influence
of correlation on regularized estimation has been studied extensively—see, for ex-
ample, (Dalalyan, Hebiri and Lederer (2017)) and (Hebiri and Lederer (2013)) for
the lasso case. The most straightforward extension of our theories goes via the `∞-
restricted eigenvalue introduced in (Chichignound, Lederer and Wainwright (2016)).
This condition allows for design matrices, that satisfy ||X>Xδ||∞ & ||δ||∞ for cer-
tain δ. We omit the details; importantly, our simulations demonstrate that our
method provides accurate prediction far beyond orthonormal design.
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